LIPUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.2 SEK | -6.82% |
|
-6.29% | +25.77% |
| 06-18 | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
| 05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIPUM AB | Biopharmaceuticals | -6.82% | -6.29% | +25.77% | -5.75% | - | 16.41M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LIPUM Stock
- Charts Lipum AB
- Comparison Chart
